Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

ACRX

AcelRX Pharmaceuticals (ACRX)

AcelRX Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ACRX
DateTimeSourceHeadlineSymbolCompany
03/06/20234:41PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/01/20238:30AMPR Newswire (US)AcelRx Pharmaceuticals Announces Peer-Reviewed Publication On the Use of DSUVIA® For In-Office Rhinology ProceduresNASDAQ:ACRXAcelRX Pharmaceuticals Inc
02/14/20234:55PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
02/08/20234:52PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
02/08/20234:50PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
02/08/20234:47PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
12/28/20225:27PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
12/27/20226:31PMValueWalkThree Healthcare Penny Stocks To Watch In The New YearNASDAQ:ACRXAcelRX Pharmaceuticals Inc
12/27/20228:30AMPR Newswire (US)AcelRx Announces $7.5 Million Registered Direct Offering of Common Stock and Warrants to Purchase Common StockNASDAQ:ACRXAcelRX Pharmaceuticals Inc
12/08/20228:30AMPR Newswire (US)AcelRx Pharmaceuticals Announces European Peer-Reviewed Publication Supporting the Benefits of Sublingual Sufentanil Tablets For Post-Operative Pain Management in the Journal of Clinical MedicineNASDAQ:ACRXAcelRX Pharmaceuticals Inc
12/05/20225:26PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/22/20224:30PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(7) (424b7)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/14/20224:56PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/14/20224:19PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/14/20224:01PMPR Newswire (US)AcelRx Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/03/20228:30AMPR Newswire (US)AcelRx to Host Third Quarter 2022 Financial Results Call and Webcast on November 14, 2022NASDAQ:ACRXAcelRX Pharmaceuticals Inc
10/31/20228:30AMPR Newswire (US)AcelRx Pharmaceuticals Announces Presentation of a Large Cohort of Complex Plastic Surgery Procedures Performed with DSUVIA at Plastic Surgery The Meeting 2022NASDAQ:ACRXAcelRX Pharmaceuticals Inc
10/27/20228:30AMPR Newswire (US)AcelRx Pharmaceuticals Announces the European Launch of DZUVEO by its Partner, AguettantNASDAQ:ACRXAcelRX Pharmaceuticals Inc
10/26/20228:30AMPR Newswire (US)AcelRx Pharmaceuticals Announces Presentation of Investigator-Initiated Trial Results Comparing AcelRx's Sufentanil Sublingual Tablet (SST) Versus Intravenous Opioids for Postoperative Pain at the ANESTHESIOLOGY® Annual Meeting 2022NASDAQ:ACRXAcelRX Pharmaceuticals Inc
10/25/20224:52PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
10/25/20224:42PMPR Newswire (US)AcelRx Pharmaceuticals Announces Reverse Stock SplitNASDAQ:ACRXAcelRX Pharmaceuticals Inc
10/25/20228:30AMPR Newswire (US)AcelRx Pharmaceuticals Announces ANESTHESIOLOGY® 2022 Annual Meeting Presentation on DSUVIA® for Battlefield Analgesia by the Uniformed Services University of the Health SciencesNASDAQ:ACRXAcelRX Pharmaceuticals Inc
09/23/20224:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
09/06/20224:30PMPR Newswire (US)AcelRx Pharmaceuticals to Participate in the H.C. Wainwright Annual Investment ConferenceNASDAQ:ACRXAcelRX Pharmaceuticals Inc
08/25/20228:30AMPR Newswire (US)AcelRx Pharmaceuticals Announces a Second Abstract on DSUVIA® Accepted for Presentation at the ANESTHESIOLOGY® 2022 Annual MeetingNASDAQ:ACRXAcelRX Pharmaceuticals Inc
08/12/20224:58PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
08/12/20224:10PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
08/11/20225:02PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
08/11/20224:10PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
08/11/20224:01PMPR Newswire (US)AcelRx Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:ACRXAcelRX Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ACRX